Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$259M |
| 2 |
Alibaba
BABA
|
+$250M |
| 3 |
Under Armour
UAA
|
+$195M |
| 4 |
Wabtec
WAB
|
+$192M |
| 5 |
Interactive Brokers
IBKR
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$353M |
| 2 |
LNKD
LinkedIn Corporation
LNKD
|
+$312M |
| 3 |
HAPN
Happen Inc
HAPN
|
+$287M |
| 4 |
Qualcomm
QCOM
|
+$244M |
| 5 |
PX
Praxair Inc
PX
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.88% |
| 2 | Communication Services | 19.56% |
| 3 | Healthcare | 12.38% |
| 4 | Financials | 9.29% |
| 5 | Technology | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PX
151
DELISTED
Praxair Inc
PX
| $10.4M | 0.02% |
92,284
-2,105,827
| -96% | -$239M |
|
152
American Water Works
AWK
$26.7B
| $10.3M | 0.02% |
122,159
-151,540
| -55% | -$11.3M |
|
153
Estee Lauder
EL
$30.4B
| $10.2M | 0.02% |
111,584
| – | – |
|
|
STMP
154
DELISTED
Stamps.com, Inc.
STMP
| $9.98M | 0.02% |
114,150
-65,000
| -36% | -$5.8M |
|
155
Donaldson
DCI
$10.9B
| $9.97M | 0.02% |
290,081
| – | – |
|
|
AFT
156
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
| $9.76M | 0.02% |
617,746
| – | – |
|
157
PACCAR
PCAR
$69.8B
| $9.56M | 0.02% |
276,371
| – | – |
|
158
SLB Ltd
SLB
$73.6B
| $9.42M | 0.02% |
119,127
| – | – |
|
159
Sherwin-Williams
SHW
$82.7B
| $9.17M | 0.02% |
93,708
| – | – |
|
160
Veeco
VECO
$3.05B
| $9.15M | 0.02% |
552,644
| – | – |
|
|
VAR
161
DELISTED
Varian Medical Systems, Inc.
VAR
| $8.28M | 0.01% |
114,799
| – | – |
|
162
Stratasys
SSYS
$679M
| $8.15M | 0.01% |
356,100
-160,200
| -31% | -$3.75M |
|
|
SCTY
163
DELISTED
SolarCity Corporation
SCTY
| $7.49M | 0.01% |
312,900
| – | – |
|
164
Pacira BioSciences
PCRX
$1.04B
| $7.21M | 0.01% |
213,600
+186,100
| +677% | +$9.15M |
|
|
CSLT
165
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $7.11M | 0.01% |
1,794,820
| – | – |
|
|
NVDQ
166
DELISTED
Novadaq Technologies Inc.
NVDQ
| $6.93M | 0.01% |
704,480
| – | – |
|
|
ELLI
167
DELISTED
Ellie Mae Inc
ELLI
| $6.51M | 0.01% |
71,000
| – | – |
|
168
AeroVironment
AVAV
$7.56B
| $6.36M | 0.01% |
228,710
| – | – |
|
|
EXA
169
DELISTED
EXA Corporation
EXA
| $6.06M | 0.01% |
419,630
| – | – |
|
170
Digimarc Corp
DMRC
$147M
| $5.58M | 0.01% |
174,500
+20,000
| +13% | +$572K |
|
171
PayPal
PYPL
$48.9B
| $5.55M | 0.01% |
151,960
| – | – |
|
172
EPAM Systems
EPAM
$5.51B
| $5.46M | 0.01% |
84,900
-110,000
| -56% | -$8.03M |
|
173
Codexis
CDXS
$151M
| $4.78M | 0.01% |
1,185,133
+200,000
| +20% | +$732K |
|
|
FARO
174
DELISTED
Faro Technologies
FARO
| $4.2M | 0.01% |
124,080
| – | – |
|
175
Microchip Technology
MCHP
$40.3B
| $4.2M | 0.01% |
165,320
| – | – |
|
Similar funds
Baillie Gifford & Co's Q2 2016 Portfolio in Review
As of Q2 2016, Baillie Gifford & Co held 206 positions worth $56.1B, down 1.3% from $56.8B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Baillie Gifford & Co's Q2 2016 filing shows 9 new, 66 increased, 73 reduced and 13 closed positions. Its largest new stake was China Biologic Products Holdings, Inc.: 1,460,752 shares worth $155M. The largest sale was Amazon, an estimated $353M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 33% a quarter earlier, followed by Communication Services and Healthcare.
- Baillie Gifford & Co's largest Q2 2016 buy was China Biologic Products Holdings, Inc.: 1,460,752 shares worth $155M.
- Baillie Gifford & Co added most to Tesla in Q2 2016, an estimated $259M increase.
- Baillie Gifford & Co's biggest Q2 2016 reduction was Amazon, cutting an estimated $353M.
- Baillie Gifford & Co fully exited Happen Inc in Q2 2016, selling an estimated $287M.
- Baillie Gifford & Co's ten largest holdings make up 49% of its $56.1B portfolio in Q2 2016.
- Baillie Gifford & Co opened 9 new positions and closed 13 in Q2 2016.
- Baillie Gifford & Co's portfolio value fell 1.3% quarter-over-quarter to $56.1B.
Based on Baillie Gifford & Co's 13F filing for Q2 2016, filed 9 Aug 2016.